Welcure Drugs & Pharmaceuticals has reported fresh export orders amounting to approximately Rs. 300 crore in the first quarter of FY26, underscoring the company’s expanding global footprint and the sustained international appetite for its pharmaceutical products. This development highlights Welcure’s growing penetration into regulated and semi-regulated markets, as well as its strategic emphasis on building robust overseas partnerships.
